Huang XC

No ORCID on file · 1 paper in corpus

2026

piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation.

Cellular & molecular biology letters ·doi:10.1186/s11658-026-00969-x

BackgroundSurvival rates for ovarian cancer drop sharply at late-stages due to late diagnosis. Although PARP inhibitors are effective in homologous recombination-deficient (HRD) tumors, their efficacy in homologous recombination (HR)-profic…